>latest-news

Biopharma Leadership In India Strengthens At The 9th Biologics Festival India & 15th Vaccine World Summit 2025

India strengthens its role in biologics and vaccines at #BFI2025 & #VWS2025, fostering global collaboration.

Breaking News

  • Mar 11, 2025

  • Simantini Singh Deo

Biopharma Leadership In India Strengthens At The 9th Biologics Festival India & 15th Vaccine World Summit 2025

Pune, India, 4-5 March 2025, The 9th Biologics Festival India 2025 (#BFI2025) and the 15th Annual Vaccine World Summit 2025 (#VWS2025) came to a conclusion in Pune. These two events were successful in bringing more than 600 industry professionals, 150+ top companies and renowned experts from the pharma industry to explore and discuss the future of biologics and vaccines in emerging markets. 

Encouraging creativity and collaboration within the area of vaccine and biologics development was the fundamental purpose of these events. Both events brought together more than fifty industry leaders while delivering thirty-plus informative panel discussions and eight case studies and generated more than 20 hours of productive networking time for participants and industry associates. Members from R&D, manufacturing, and regulatory bodies and supply chains joined forces at the conference to study industry challenges and possibilities. 


Key Highlights From Both The Events:

  • Valuable Discussions: Experts addressed cutting-edge advancements in biopharmaceuticals, regulatory pathways, and emerging technologies, offering applicable insights into process development and commercialization strategies.

  • Global Impact: As India plays a significant role in vaccine and biologics manufacturing, a lot of panel discussions were centred on enhancing production efficiency, the strength of the supply chain, and increasing access to life-saving treatments, specifically when it comes to developing nations.

  • Networking & Collaboration: Attendees connected with industry pioneers, forming strategic partnerships in order to promote progress in the accessibility of vaccine and biologics innovation.


Today, India remains dynamic in leadership and innovations in biologics and vaccine development. The knowledge and connections derived from these two major events will establish the foundation for a powerful pharmaceutical industry future. Healthcare sector accessibility, together with innovation and affordability, will improve through the partnerships formed at these major events. 

The accomplishment of these two events demonstrates India's rising dominance in global biologics and vaccine business operations. However, if you want to keep yourself updated about the pharma world, visit Pharma Now today! 

Ad
Advertisement